Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma.
J Immunol. 2011 Jul 15;187(2):1047-56. doi: 10.4049/jimmunol.1002460. Epub 2011 Jun 15.
J Immunol. 2011.
PMID: 21677134
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.
Herth I, Witzens-Harig M, Beckhove P, Hose D, Meissner T, Neuber B, Engelhardt M, Haas J, Neben K, Ho AD, Klein B, Goldschmidt H, Hundemer M.
Herth I, et al.
Exp Hematol. 2013 Mar;41(3):231-40. doi: 10.1016/j.exphem.2012.10.018. Epub 2012 Nov 8.
Exp Hematol. 2013.
PMID: 23142220
Free article.
Clinical Trial.
Item in Clipboard
[Acute dyspnea, subfebrile temperatures and chills in a patient with multiple myeloma].
Merz M, Herth I, Brandt J, Hundemer M, Neben K, Goldschmidt H, Heußel CP.
Merz M, et al. Among authors: herth i.
Med Klin Intensivmed Notfmed. 2014 Mar;109(2):137-40. doi: 10.1007/s00063-013-0298-z. Epub 2013 Oct 23.
Med Klin Intensivmed Notfmed. 2014.
PMID: 24145709
German.
No abstract available.
Item in Clipboard
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
Herth I, Hensel M, Rieger M, Horstmann K, Hiddemann W, Dreyling M, Koniczek S, Witzens-Harig M, Ho AD.
Herth I, et al.
Leuk Lymphoma. 2015 Jan;56(1):97-102. doi: 10.3109/10428194.2014.911869. Epub 2014 Jun 25.
Leuk Lymphoma. 2015.
PMID: 24724778
Clinical Trial.
Item in Clipboard
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison.
Herth I, Dietrich S, Benner A, Hegenbart U, Rieger M, Stadtherr P, Bondong A, Tran TH, Weide R, Hensel M, Knauf W, Franz-Werner J, Welslau M, Procaccianti M, Görner M, Meissner J, Luft T, Schönland S, Witzens-Harig M, Zenz T, Ho AD, Dreger P.
Herth I, et al.
Ann Oncol. 2014 Jan;25(1):200-6. doi: 10.1093/annonc/mdt511.
Ann Oncol. 2014.
PMID: 24356631
Free article.
Item in Clipboard
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse.
Hahn M, Böttcher S, Dietrich S, Hegenbart U, Rieger M, Stadtherr P, Bondong A, Schulz R, Ritgen M, Schmitt T, Tran TH, Görner M, Herth I, Luft T, Schönland S, Witzens-Harig M, Zenz T, Kneba M, Ho AD, Dreger P.
Hahn M, et al. Among authors: herth i.
Bone Marrow Transplant. 2015 Oct;50(10):1279-85. doi: 10.1038/bmt.2015.150. Epub 2015 Jul 6.
Bone Marrow Transplant. 2015.
PMID: 26146810
Item in Clipboard
Cite
Cite